News & Media

Take a look inside our world

Press Releases

Teva to Present Data Demonstrating UZEDY™ (risperidone) Extended-Release Injectable Suspension Signi...

Teva to Present Data Demonstrating UZEDY™ (risperidone) Extended-Release Injectable Suspension Significan

Teva Launches New “Pivot to Growth” Strategy

Teva Launches New “Pivot to Growth” Strategy

AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, New Once-Daily Formulation of AUSTEDO®, Now...

AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, New Once-Daily Formulation of AUSTEDO®, Now Avai

Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook

Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook

Teva Shares Progress Toward Access to Medicines and Environmental Commitments, Meeting and Exceeding...

Teva Shares Progress Toward Access to Medicines and Environmental Commitments, Meeting and Exceeding Seve

U.S. Mental Health Access Program Expands Medicine Donation to Seven New States

U.S. Mental Health Access Program Expands Medicine Donation to Seven New States

Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspens...

Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension,

Teva to Launch New Growth Strategy at Investor Day

Teva to Launch New Growth Strategy at Investor Day

Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10,...

Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10, 2023

Complete Response Letter Received for AVT02 Biologics License Application

Complete Response Letter Received for AVT02 Biologics License Application

Contacts for Media Inquiries

Kelley Dougherty

North America

+1-973-658-0237
Kelley.Dougherty@tevapharm.com

Eden Klein

Israel & Corporate

+972-3-9062645
Eden.Klein@teva.co.il

Leslie McGibbon

Europe

Leslie.Mcgibbon@Tevaeu.com


Teva Media Assets

These proprietary media assets are available for download and are intended for non-commercial media use and research only.

Download Logo Download Teva B-Roll

Feature stories


Connect with us on social media

Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Follow us on Twitter

Go to twitter.com

View our Social Media Guidelines

Learn more